The Acquisition And Implementation Of An Existing Corporate Platform In The Market That Allows The Automated Management Of Genomic And Cytogenomic Data For The Cantabrian Health Service.

Name: The Acquisition And Implementation Of An Existing Corporate Platform In The Market That Allows The Automated Management Of Genomic And Cytogenomic Data For The Cantabrian Health Service.
Start: 2025-08-05
End: 2025-08-18
Location: Servicio Cantabro de Salud

Servicio Cantabro de Salud Spain has Released a tender for The Acquisition And Implementation Of An Existing Corporate Platform In The Market That Allows The Automated Management Of Genomic And Cytogenomic Data For The Cantabrian Health Service. in Software Services. The tender was released on Aug 04, 2025.

Country - Spain

Summary - The Acquisition And Implementation Of An Existing Corporate Platform In The Market That Allows The Automated Management Of Genomic And Cytogenomic Data For The Cantabrian Health Service.

Deadline - Aug 18, 2025

GT reference number - 114874326

Product classification - IT services: consulting, software development, Internet and support

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 114874326

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This system will be designed to index, capture and draw all the phases of the genomic process, ensuring efficient and centralized management of the data. In addition, interoperability will be guaranteed with other existing clinical infor mation systems, promoting sustainable and equitable use of health resources.local title:: La adquisición e implantación de una plataforma corporativa existente en el mercado que permita la gestión automatizada de datos genómicos y citogenómicos para el servicio cántabro de salud.Contract Duration: : 24 MONTHContract Type: : Servicelocal description: : Este sistema estará diseñado para indexar, capturar y trazar todas las fases del proceso

Gt Ref Id - 114874326

Deadline - Aug 18, 2025